Ideally a new treatment for adults and children will be a macrofilaricide (efficacious against the adult form of worms), oral, short-course treatment, well tolerated, affordable, and adapted to tropical climates.

The current filarial diseases portfolio includes:

 

Translation

Translation

Emodepside
ABBV-4083 TylaMac
Macro Filaricide 3

 

For more details on each project, see DNDi‘s Global Portfolio